Bleakley Financial Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.8M Buy
159,361
+2,097
+1% +$93.7K 0.09% 185
2026
Q1
$7.58M Buy
157,264
+27,674
+21% +$1.29M 0.12% 146
2025
Q4
$6.28M Buy
129,590
+8,986
+7% +$445K 0.11% 160
2025
Q3
$5.69M Buy
120,604
+2,924
+2% +$141K 0.13% 137
2025
Q2
$5.69M Buy
117,680
+3,890
+3% +$199K 0.14% 134
2025
Q1
$6.31M Sell
113,790
-3,772
-3% -$204K 0.2% 98
2024
Q4
$5.67M Sell
117,562
-3,069
-3% -$156K 0.17% 102
2024
Q3
$6.95M Buy
120,631
+4,190
+4% +$226K 0.21% 80
2024
Q2
$5.65M Buy
116,441
+8,068
+7% +$389K 0.16% 121
2024
Q1
$5.27M Buy
108,373
+11,949
+12% +$583K 0.15% 132
2023
Q4
$4.8M Buy
96,424
+20,984
+28% +$1.03M 0.15% 129
2023
Q3
$4.05M Buy
75,440
+1,779
+2% +$94.8K 0.14% 133
2023
Q2
$3.97M Sell
73,661
-734
-1% -$39.5K 0.12% 151
2023
Q1
$4.05M Sell
74,395
-1,524
-2% -$74.1K 0.14% 145
2022
Q4
$3.68M Buy
+75,919
New +$3.33M 0.13% 154

Other funds holding SNY

Bleakley Financial Group's SNY Position: Q2 2026 in Review

Bleakley Financial Group increased its Sanofi (SNY) stake by 1.3% in Q2 2026, buying an estimated $93.7K and bringing the position to 159,361 shares worth $6.8M. The position accounts for 0.09% of the portfolio, ranked #185.

Bleakley Financial Group first reported a position in SNY in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.58M in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Bleakley Financial Group held 159,361 shares of Sanofi worth $6.8M as of Q2 2026.
  • Bleakley Financial Group bought 2,097 Sanofi shares in Q2 2026, an estimated $93.7K.
  • Sanofi made up 0.09% of Bleakley Financial Group's portfolio in Q2 2026, its #185 holding.
  • Bleakley Financial Group first reported a position in Sanofi in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Sanofi position peaked at $7.58M in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.